Dr. Pan has over 20 years of computational biology and computational drug design experiences in small molecule, protein and RNA medicine. Dr. Pan hold a PhD in computational chemistry from the University of Alabama at Birmingham, a master’s in artificial intelligence from Georgia Tech. Dr. Pan was a Senior Scientist and Director at University of Alabama at Birmingham Medical School. She was previously a Senior Investigator at Global Health Drug Discovery Institute, a non-profit research institute founded by the Bill & Melinda Gates Foundation. She received the Pandemic Preparedness Award from Merck in 2020.
Kevin brings over 10 years of experience in biomedical AI/ML and drug discovery research, spanning both academic and industry product development. Previously, he has a strong track record of translating cutting-edge AI technologies into practical business solutions across diverse industries, driving measurable improvements in ROI and operational efficiency. Kevin holds a B.S. in Biomedical Engineering from the University of Rochester and an M.S. in Biomedical Engineering from Columbia University.
Roger has over 6 years of experience in AI/ML platform Engineering and data engineering with multiple industrial experiences. He holds a MS in Data Science from the University of Southern California.
Grace Kuo is a AI Software Engineer with a cross-disciplinary background spanning health science, enterprise systems, and applied AI. She holds a Master’s degree in Computer Science (AI) from Georgia Tech and a Bachelor's in Nutrition Science. Grace now focuses on delivering AI-powered products that bridge research and real-world use. She specializes in turning complex technologies into impactful, scalable solutions.
Len Brioso has over 4 years of commercial experience in account management, executive support, and marketing. She demonstrated record of excellence in client relationship management, customer retention, and strategic problem-solving.
Dr. Tanik was a professor and holds the Wallace R. Bunn Endowed Chair for Computer Engineering Department. He co-directs UAB’s Integrated Systems Center and co-founded the Society for Design and Process Science (SDPS). He held leadership roles that included directing the Software Systems Engineering Institute at The University of Texas at Austin and the Electronic Enterprise Engineering program at NJIT. His research spans artificial Intelligence, information-theoretic foundations of software, and applications across engineering, medicine, and biology. He earned his Ph.D. in computer science from Texas A&M University.
Dr. Brewer is a scientist with expertise in molecular biophysics, regenerative medicine, and AI-driven drug development. He serves as Associate Director of Advanced Drug Delivery and Regenerative Biomaterials at Stanford University. His prior roles include co-founding ETTA Biotechnology to develop AI-designed small molecules, contributing to biological model tuning at OpenAI, and advancing mRNA therapies at Rejuvenation Technologies. Dr. Brewer earned his Ph.D. in Molecular Biophysics from UT Southwestern and holds dual degrees in Biochemistry and Chemistry from North Carolina State University.
Dr. Sheng Ding is a Professor at the University of California, San Francisco and the Founding Dean and Bayer Distinguished Professor at Tsinghua University’s School of Pharmaceutical Sciences. He is the Institute Director of the Global Health Drug Discovery Institute and a Co-founder of multiple biotech companies such as Fate Therapeutics, Tenaya Therapeutics, and Retro Biosciences. He pioneered the development and application of innovative chemical approaches to control stem cell fate and drive regeneration."
